☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Europe
Coave Signs an Exclusive License Agreement with Théa to Co-Development and Commercialize CTx-PDE6b for PDE6b Associated Retinitis...
September 17, 2021
Coave Signs an Exclusive License Agreement with Théa to Co-Development and Commercialize CTx-PDE6b for PDE6b Associated Retinitis...
September 17, 2021
Almirall and Kaken Enter into a License Agreement for the Development and Commercialization of Efinaconazole in Europe
July 2, 2021
Almirall and Kaken Enter into a License Agreement for the Development and Commercialization of Efinaconazole in Europe
July 2, 2021
PharmaShots Interview: GSK's Mike Crichton Shares Insights on the Approval of Benlysta in Europe
June 8, 2021
PharmaShots Interview: GSK's Mike Crichton Shares Insights on the Approval of Benlysta in Europe
June 8, 2021
Load more...
Back to Home